Compare Unichem Lab with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB FRESENIUS KABI ONCO. UNICHEM LAB/
FRESENIUS KABI ONCO.
 
P/E (TTM) x -98.8 22.1 - View Chart
P/BV x 0.5 3.1 17.4% View Chart
Dividend Yield % 2.6 0.0 -  

Financials

 UNICHEM LAB   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
FRESENIUS KABI ONCO.
Mar-13
UNICHEM LAB/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs292176 165.9%   
Low Rs18279 231.8%   
Sales per share (Unadj.) Rs167.737.7 444.9%  
Earnings per share (Unadj.) Rs-3.65.1 -71.3%  
Cash flow per share (Unadj.) Rs5.96.7 88.4%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.342.5 875.0%  
Shares outstanding (eoy) m70.38158.23 44.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.43.4 41.9%   
Avg P/E ratio x-65.325.0 -261.3%  
P/CF ratio (eoy) x39.918.9 210.7%  
Price / Book Value ratio x0.63.0 21.3%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,68020,135 82.8%   
No. of employees `0002.61.2 225.9%   
Total wages/salary Rs m2,393703 340.3%   
Avg. sales/employee Rs Th4,535.25,176.2 87.6%   
Avg. wages/employee Rs Th919.8610.4 150.7%   
Avg. net profit/employee Rs Th-98.2699.6 -14.0%   
INCOME DATA
Net Sales Rs m11,8015,963 197.9%  
Other income Rs m98418 5,467.2%   
Total revenues Rs m12,7855,981 213.8%   
Gross profit Rs m-8351,430 -58.4%  
Depreciation Rs m674258 261.2%   
Interest Rs m75-26 -289.2%   
Profit before tax Rs m-6001,216 -49.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m-343342 -100.4%   
Profit after tax Rs m-256806 -31.7%  
Gross profit margin %-7.124.0 -29.5%  
Effective tax rate %57.328.1 203.6%   
Net profit margin %-2.213.5 -16.0%  
BALANCE SHEET DATA
Current assets Rs m20,3845,102 399.6%   
Current liabilities Rs m5,0292,385 210.8%   
Net working cap to sales %130.145.6 285.7%  
Current ratio x4.12.1 189.5%  
Inventory Days Days105150 69.8%  
Debtors Days Days135113 119.1%  
Net fixed assets Rs m9,0235,148 175.3%   
Share capital Rs m141158 89.0%   
"Free" reserves Rs m26,0586,556 397.5%   
Net worth Rs m26,1996,732 389.2%   
Long term debt Rs m0952 0.0%   
Total assets Rs m31,49610,388 303.2%  
Interest coverage x-7.0-45.8 15.2%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.40.6 65.3%   
Return on assets %-0.67.5 -7.6%  
Return on equity %-1.012.0 -8.1%  
Return on capital %-2.014.6 -13.7%  
Exports to sales %69.474.5 93.2%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs m8,1884,441 184.4%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m8,1885,298 154.6%   
Fx outflow Rs m5961,772 33.6%   
Net fx Rs m7,5923,525 215.4%   
CASH FLOW
From Operations Rs m-3,2781,274 -257.3%  
From Investments Rs m-2,860-1,204 237.5%  
From Financial Activity Rs m-24-196 12.3%  
Net Cashflow Rs m-4,690-126 3,713.5%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 15.1 0.3 5,033.3%  
FIIs % 3.0 9.6 31.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 9.1 348.4%  
Shareholders   20,176 42,599 47.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PANACEA BIOTECH  DIVIS LABORATORIES  FULFORD INDIA  NATCO PHARMA  ELDER PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

CSB Bank IPO, October Passenger Vehicle Sales, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets witnessed buying interest during closing hours and ended on a positive note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 19, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS